Results 181 to 190 of about 1,282,605 (359)

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

open access: yesMolecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla   +10 more
wiley   +1 more source

Lifetime History of Suicide Attempts among Not Guilty by Reason of Insanity State Hospital Inpatients: The Roles of past Harmful Substance Use and Current Social Support

open access: green, 2020
Sean M. Mitchell   +7 more
openalex   +2 more sources

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

State Hospital, Carstairs [PDF]

open access: yesBulletin of the Royal College of Psychiatrists, 1978
openaire   +1 more source

Comparison of serum oxidative stress markers among male partners of fertile and infertile couple at Nnamdi Azikiwe University Teaching Hospital, Nnewi, Anambra State, Nigeria

open access: bronze, 2017
Okafor Chidimma Donatus   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy